ROCCHETTI, MARCELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.202
EU - Europa 4.569
AS - Asia 3.620
SA - Sud America 503
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 2
Totale 15.957
Nazione #
US - Stati Uniti d'America 6.994
SG - Singapore 1.419
IT - Italia 1.032
DE - Germania 986
CN - Cina 920
RU - Federazione Russa 523
HK - Hong Kong 429
VN - Vietnam 405
BR - Brasile 404
SE - Svezia 381
IE - Irlanda 293
PL - Polonia 287
GB - Regno Unito 258
UA - Ucraina 193
FR - Francia 174
CA - Canada 149
AT - Austria 116
FI - Finlandia 100
IN - India 98
DK - Danimarca 60
KR - Corea 60
ID - Indonesia 59
TR - Turchia 59
NL - Olanda 52
JP - Giappone 47
AR - Argentina 44
MX - Messico 40
BD - Bangladesh 28
BE - Belgio 28
ZA - Sudafrica 24
EC - Ecuador 20
ES - Italia 19
IQ - Iraq 18
PK - Pakistan 13
BG - Bulgaria 12
CH - Svizzera 11
LT - Lituania 11
EU - Europa 9
IR - Iran 9
CO - Colombia 8
TW - Taiwan 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
JO - Giordania 7
MA - Marocco 7
PT - Portogallo 6
UY - Uruguay 6
UZ - Uzbekistan 6
CL - Cile 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
PY - Paraguay 4
RO - Romania 4
AZ - Azerbaigian 3
BB - Barbados 3
CR - Costa Rica 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
SC - Seychelles 3
AO - Angola 2
AU - Australia 2
BH - Bahrain 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 15.957
Città #
Ann Arbor 1.270
Singapore 874
Ashburn 686
Frankfurt am Main 606
Woodbridge 528
Wilmington 452
Hong Kong 423
Fairfield 411
Chandler 345
Milan 341
Houston 327
Dublin 288
Kraków 263
Seattle 185
Jacksonville 179
Dearborn 171
New York 165
Beijing 156
Cambridge 148
Dallas 130
Santa Clara 130
Los Angeles 123
Hefei 118
Vienna 109
Ho Chi Minh City 100
Princeton 91
Dong Ket 80
Nanjing 73
Shanghai 73
Hanoi 62
Buffalo 58
Seoul 53
The Dalles 52
Jakarta 50
Chicago 49
Helsinki 42
Lawrence 41
São Paulo 40
Moscow 39
Munich 39
Altamura 33
Toronto 32
Lachine 31
Brussels 28
Montréal 28
Torino 27
Nanchang 26
Council Bluffs 25
Fremont 25
Guangzhou 25
Tokyo 25
Denver 24
San Diego 23
Boardman 21
London 21
Montreal 21
Warsaw 20
Zhengzhou 20
Turin 19
Nuremberg 18
Rome 18
Columbus 17
Hyderabad 17
Orem 17
Poplar 17
Shenyang 17
Rio de Janeiro 16
Sanayi 16
Ankara 15
Brooklyn 15
Jiaxing 15
Jinan 15
Changsha 14
Chennai 14
Stockholm 14
Andover 13
Falls Church 13
Haiphong 13
Hebei 13
Huizen 13
Manchester 13
Ottawa 13
San Jose 13
Tianjin 13
Atlanta 12
Boston 12
Mexico City 12
Pune 12
Turku 12
Verona 12
Como 11
Da Nang 11
Florence 11
Kunming 11
Monza 11
Phoenix 11
Edmonton 10
Johannesburg 10
Kent 10
Lappeenranta 10
Totale 10.394
Nome #
Late sodium current and intracellular ionic homeostasis in acute ischemia 435
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 429
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 426
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 420
Action potential contour contributes to species differences in repolarization response to b-adrenergic stimulation 419
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 406
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 376
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function 362
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension 356
Calcium store stability as an antiarrhythmic endpoint 344
Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains 341
Caffeine-induced Ca(2+) signaling as an index of cardiac progenitor cells differentiation 340
Late sodium current (INaL) in pancreatic β-cells 336
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension 333
CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation 325
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 321
Altered functional differentiation of mesoangioblasts in a genetic myopathy 320
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 320
Human induced pluripotent stem cells derived from a cardiac somatic source: insights for an in-vitro cardiomyocyte platform 315
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 312
A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 309
Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse 305
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy 305
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 303
Modulation of sarcoplasmic reticulum function by istaroxime (PST2744) in a pressure-overload heart failure model 300
Interstitial pressure and lung oedema in chronic hypoxia 296
Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity 290
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp 290
Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling 287
Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function 284
Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride]. 280
Liraglutide preserves CD34+ stem cells from dysfunction Induced by high glucose exposure 275
Modulation of sympathetic activity and heart rate variability by ivabradine 270
A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot 266
Rate dependency of beta-adrenergic modulation of repolarizing currents in the guinea-pig ventricle 263
Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging 244
The late Na+ current--origin and pathophysiological relevance 235
The role of the autonomic system in rate-dependent repolarization changes 233
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744) 228
Intracellular Ca2+ dynamics in isolated Vascular Smooth Muscle Cells (VSMCs) from rat distal pulmonary artery through a non enzimatic method 224
Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest 222
Diverse toxicity associated with cardiac Na+/K+ pump inhibition: Evaluation of electrophysiological mechanisms 209
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab 208
Fisiologia normale e patologia dell'atrio 207
Identification and functional characterisation of a new KCNJ2 mutation 207
Regulation of the sinoatrial pacemaker. Selective If inhibition by ivabradine 206
Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function 204
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes 195
Mechanisms of beta-adrenergic modulation of I(Ks) in the guinea-pig ventricle: insights from experimental and model-based analysis 194
Selective SERCA2a activator as a candidate for chronic heart failure therapy 184
Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation 181
Striatin knock out induces a gain of function of INa and impaired Ca2+ handling in mESC‐derived cardiomyocytes 178
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment 166
Intracellular Ca2+ dynamics modulation by istaroxime and its metabolite in pulmonary artery smooth muscle cells. 166
Recombinant hSERCA2a in yeast microsomes: a new tool for mechanistic studies on drug-induced SERCA2a stimulation 144
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy (DCM) 141
The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function 141
In-vitro studies of the NaV1.5 S805L Brugada mutation: The resting cell voltage is a critical element in determining the pathological or physiological phenotype of the current 140
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro 125
INTRACELLULAR Ca 2+ DYNAMICS MODULATION BY ISTAROXIME AND ITS METABOLITE IN PULMONARY ARTERY SMOOTH MUSCLE CELLS 114
Hypokalemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation 74
YAP1 reactivation in cardiomyocytes following ECM remodelling contributes to the development of contractile force and sarcomere maturation 30
Development of Small-molecule SERCA2a Stimulators: A Novel Class of Ino-lusitropic Agents 20
Totale 16.379
Categoria #
all - tutte 50.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021906 0 0 0 0 0 130 83 95 100 180 113 205
2021/20221.134 99 102 114 93 53 108 64 42 56 105 99 199
2022/20231.826 207 482 205 183 169 229 37 85 102 35 57 35
2023/20241.181 47 45 67 73 110 267 212 68 73 33 69 117
2024/20253.063 125 301 358 144 227 143 155 129 257 476 225 523
2025/20263.511 767 355 483 691 853 362 0 0 0 0 0 0
Totale 16.379